Overview

A Post-authorization Study to Describe the Safety and Efficacy of Emapalumab for the Treatment of pHLH in Treatment Experienced Chinese Patients

Status:
Recruiting

Trial end date:
2025-07-01

Target enrollment:

Participant gender:

Summary

The goal of this post-authorization study is to describe safety and efficacy of emapalumab in treatment experienced Chinese patients with pHLH.

Phase:

Phase 4

Details

Lead Sponsor:

Swedish Orphan Biovitrum